Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.
Explore how PBSCs enabled CAR-T and immune effector cell therapies, and how Biovault supports safe processing, storage and delivery of advanced cellular medicines.
How peripheral blood stem cells became the preferred source for transplantation, and how Biovault supports PBSC collection pathways through compliant processing and storage.
How Biovault Technical engineered new cryoshipper racks and CRF freezer racks to enhance safety, usability and compliance for cellular therapies.
As the UK’s ethical bioresource, Biovault is leading the way in slashing processing and storage emissions as part of its pledge to achieve Net Zero.